Hyperkalemia, or elevated potassium in the blood, disrupts the heart’s electrical system in ways that range from subtle rhythm changes to cardiac arrest. Normal potassium levels fall below 5.0 mEq/L, and cardiac risk climbs meaningfully once levels exceed 6.0 mEq/L. The higher the potassium goes, and the faster it rises, the more dangerous the effects become.
How Potassium Controls Your Heartbeat
Your heart beats because of precisely timed electrical signals that travel through cardiac muscle cells. Those signals depend on a voltage difference across each cell’s membrane, created largely by the balance of potassium inside the cell versus outside it. Normally, potassium is heavily concentrated inside heart cells and relatively scarce outside them. This imbalance creates a resting electrical charge of about negative 90 millivolts, essentially a coiled spring waiting to fire.
When potassium builds up in the blood, the gap between inside and outside the cell shrinks. That shifts the resting charge from negative 90 toward something like negative 80 or negative 70 millivolts. This matters because the resting charge determines how many sodium channels (the tiny gates that trigger each heartbeat’s electrical impulse) are available to open. As the resting charge drifts upward, fewer sodium channels can activate, and the electrical impulse that drives each heartbeat becomes weaker and slower.
There’s actually a brief paradox at mildly elevated levels. Because the resting charge moves closer to the activation threshold, cells initially become slightly easier to trigger. But once potassium climbs high enough that sodium channels start locking into an inactive state, conduction velocity drops sharply. This biphasic pattern, a small initial boost followed by progressive failure, helps explain why the heart’s response to rising potassium can shift quickly from manageable to life-threatening.
What Shows Up on an ECG
The heart’s electrical changes follow a roughly predictable sequence as potassium levels climb, and each stage leaves a visible signature on an electrocardiogram (ECG).
The earliest sign is usually tall, narrow, sharply peaked T waves. T waves represent the heart resetting its electrical charge between beats, and elevated potassium speeds up that process. At this stage, potassium may only be mildly elevated (around 5.5 to 6.0 mEq/L), and many people feel no symptoms at all. The PR interval and QT interval may also shorten slightly.
As levels rise into the moderate range (roughly 6.5 to 8.0 mEq/L), the electrical signal slows down across the heart. The P wave, which represents the electrical activity of the upper chambers, gets flatter and broader. The PR interval stretches out as the signal takes longer to cross from the upper to the lower chambers. The QRS complex, representing the lower chambers firing, widens as conduction through the ventricles slows. ST segment depression can also appear, and in some cases the ECG can mimic a heart attack pattern with dramatic ST elevation, a well-documented phenomenon known as a pseudo-heart attack appearance.
In severe hyperkalemia (above 8.0 mEq/L), the P wave may vanish entirely because the upper chambers can no longer conduct an organized electrical signal. The widened QRS complex begins merging with the T wave, creating a smooth, undulating pattern called a sine wave. This is a pre-arrest rhythm. Without treatment, it typically degenerates into ventricular fibrillation (a chaotic, ineffective quivering) or asystole (complete electrical silence).
Rhythm Disturbances That Can Occur
Hyperkalemia doesn’t produce just one type of arrhythmia. It can trigger a range of abnormal rhythms, and the pattern depends on the potassium level, how quickly it rose, and the patient’s underlying heart health.
Bradycardia, or a dangerously slow heart rate, is one of the most common presentations. As potassium suppresses conduction through the heart’s electrical pathways, the rate can drop well below 40 beats per minute. Case reports describe heart rates as low as 24 to 27 beats per minute in severe hyperkalemia. The specific rhythm may look like a junctional escape rhythm (where a backup pacemaker in the middle of the heart takes over) or an idioventricular rhythm (where the ventricles generate their own slow, wide-complex beats). Atrial fibrillation with an unusually slow ventricular response is another documented pattern.
At the more dangerous end of the spectrum, hyperkalemia can cause fascicular blocks and intraventricular blocks, where electrical signals are blocked in specific branches of the heart’s wiring. These conduction blocks further widen the QRS complex and can shift the heart’s electrical axis. If potassium continues to climb untreated, the disorganized conduction ultimately gives way to ventricular fibrillation or, more commonly, asystole. Both are forms of cardiac arrest.
Why Speed of Onset Matters
A potassium level of 6.5 mEq/L that develops over hours in a hospitalized patient can be far more dangerous than the same level in someone with chronic kidney disease whose potassium has been gradually drifting upward over weeks. The heart appears to tolerate slow, steady increases somewhat better than sudden spikes, likely because cells have more time to partially adapt. This doesn’t make chronic hyperkalemia safe. Progressively severe elevations still cause worsening abnormalities in the heart’s electrical activity and its ability to contract effectively, and untreated severe hyperkalemia results in sudden cardiac death regardless of how gradually it developed. But the clinical reality is that two patients with identical potassium numbers can look very different depending on how quickly they got there.
Other electrolyte imbalances amplify the danger. Low calcium, which commonly accompanies kidney disease, makes the heart more vulnerable to potassium’s effects. This is why calcium levels are routinely checked alongside potassium in people with impaired kidney function.
How the Heart Is Stabilized in an Emergency
The first priority in dangerous hyperkalemia is not lowering the potassium level. It’s protecting the heart from the potassium that’s already there. Intravenous calcium is given because it directly counteracts what elevated potassium does to cardiac cells. Calcium stabilizes the resting membrane potential, essentially raising the threshold the heart cells need to reach before they fire. This reduces the risk of dangerous rhythms within minutes. Importantly, calcium does not lower potassium levels at all. It simply buys time by making the heart less electrically irritable while other treatments work to move potassium out of the bloodstream.
After the heart is stabilized, treatment shifts to actually reducing potassium. This typically involves medications that drive potassium from the blood back into cells, agents that bind potassium in the gut so it leaves the body through stool, and in severe or refractory cases, dialysis to filter it directly from the blood. The combination of immediate cardiac protection followed by potassium reduction is what prevents the progression from ECG changes to cardiac arrest.
Who Is Most at Risk
The people most likely to develop hyperkalemia severe enough to affect the heart are those with chronic kidney disease, since the kidneys are responsible for excreting the vast majority of potassium from the body. Heart failure is another major risk factor, both because of the disease itself and because common heart failure medications (particularly certain blood pressure drugs and diuretics) can raise potassium levels. Diabetes, especially when it affects kidney function, adds further risk.
Mortality and arrhythmia rates climb notably once potassium exceeds 6.0 mEq/L, and the risk of cardiac arrest increases with every additional increment above that level. An ECG is recommended for anyone with potassium above 6.5 mEq/L, rapidly rising levels, symptoms like palpitations or weakness, or underlying conditions that make the heart more vulnerable. The gap between a concerning potassium level and a lethal one can be surprisingly narrow, which is why this electrolyte is monitored so closely in high-risk patients.